GCCL provides various services in developing and verifying analysis methods
and analyzing biomarkers based on state-of-the-art equipment
and specialists for PK/PD analysis in early clinical trial phases.
> Bio-Analytical Lab > By Platform
Immunoassay
LBA is an analytical platform that analyzes substances by the way ligand molecules bind to receptors or antibodies. It enables quantification of biomarkers and exploration of candidate substances. GCCL provides analytical services in the fields of biopharmaceutical development, biological efficacy evaluation research, and disease diagnosis using the LBA analysis platform.
Immunoassay
Flow cytometry can analyze the physical and chemical properties of cells and particles to the extent of dispersion by using a laser on cells or particles in a fluid state. GCCL provides customized analysis services in the fields of recombinant proteins and antibody drugs using flow cytometry.
Nucleic Acid Analysis
qPCR is an analytical platform that combines conventional PCR amplification and detection in one step, enabling rapid measurement and quantification of nucleic acids in various biological samples. GCCL provides PK/PD analysis diagnosis and Response Surface Model (RSM) analysis services using qPCR.
Mass Analysis
LC-MS/MS separates ions according to the molecular mass-to-charge ratio (m/z), enabling molecular weight and qualitative/quantitative analysis of substances in biological samples. GCCL utilizes LC-MS/MS to develop analysis methods based on the validation guidelines for biological sample analysis methods and provides sample analysis services.
Other Biomarkers Analysis
Cell-based assay is a platform that analyzes cell-mediated immunogenicity, and mainly uses ELISpot to quantitatively measure the secretion frequency of cytokines secreted from a single cell. GCCL utilizes the CBA analysis platform to provide various services in anti-cancer drugs and COVID-19 vaccines, etc.